Revenue: The sum of all revenue fields included for a company's operating activities.
Y-mAbs Therapeutics, Inc. (YMAB) had Revenue of $19.52M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$19.52M |
$-3.24M |
|
$2.66M |
|
$16.86M |
|
$25.13M |
|
$-5.60M |
|
$2.37M |
|
$-3.23M |
|
$-3.23M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-5.60M |
|
$-5.55M |
|
45.32M |
|
45.32M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$91.79M |
|
$0.27M |
|
$25.42M |
|
$117.21M |
|
$22.95M |
|
-- |
|
$6.77M |
|
$29.72M |
|
$87.49M |
|
$85.32M |
|
$87.49M |
|
45.44M |
|
| Cash Flow Statement Financials | |
$-5.26M |
|
$-0.13M |
|
$0.45M |
|
$67.23M |
|
$62.29M |
|
$-4.94M |
|
$6.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.37% |
|
-28.70% |
|
-28.70% |
|
-- |
|
-16.55% |
|
-16.59% |
|
$-5.39M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.27 |
|
1.24 |
|
72.55 |
|
-3.70% |
|
-3.80% |
|
-2.76% |
|
-3.70% |
|
$1.93 |
|
$-0.12 |
|
$-0.12 |
|